Page last updated: 2024-11-12

inotilone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

inotilone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11644214
SCHEMBL ID12780446
MeSH IDM0501391

Synonyms (10)

Synonym
inchi=1/c12h10o4/c1-7-4-11(15)12(16-7)6-8-2-3-9(13)10(14)5-8/h2-6,13-14h,1h3/b12-6-
nlzqgbcuknuded-sdqbbnpisa-
AKOS015896246
inotilone
GE-0217
SCHEMBL12780446
(2z)-2-[(3,4-dihydroxyphenyl)methylidene]-5-methylfuran-3-one
(2z)-2-((3,4-dihydroxyphenyl)methylene)-5-methyl-3(2h)-furanone
cn7vxc9pks ,
3(2h)-furanone, 2-[(3,4-dihydroxyphenyl)methylene]-5-methyl-, (2z)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]